Quantcast

Latest Non-alcoholic fatty liver disease Stories

2014-06-04 15:37:59

Washington University in St. Louis Studying mice, researchers have found a way to prevent nonalcoholic fatty liver disease, the most common cause of chronic liver disease worldwide. Blocking a path that delivers dietary fructose to the liver prevented mice from developing the condition, according to investigators at Washington University School of Medicine in St. Louis. The study appears in a recent issue of The Journal of Biological Chemistry. In people, nonalcoholic fatty liver...

2014-05-12 20:23:17

Dr. Michael Feiz has helped countless patients overcome such issues as obesity-related fatty liver disease LOS ANGELES, May 12, 2014 /PRNewswire/ -- People with fatty liver problems who may be considering a gastric sleeve or lap band in Beverly Hills with Dr. Michael Feiz have some new information to consider. A study of the effect of bariatric procedures on NAFLD (non-alcoholic fatty liver disease) has proven to be another weight loss surgery testimonial alongside recent evidence...

2014-05-12 08:31:08

DUBLIN and SAN DIEGO, May 12, 2014 /PRNewswire/ -- - Acquisition of Lumena Pharmaceuticals, a biopharmaceutical company with late stage rare disease pipeline assets - Adds to Shire's rare diseases portfolio and leverages this expertise, and is a perfect combination with Shire's already strong Gastrointestinal (GI) presence - Adds LUM001 in Phase 2 development for four rare and devastating hepatic diseases, two...

2014-05-07 10:40:44

Researchers from The Netherlands found that snacking on high-fat and high-sugar foods was independently associated with abdominal fat and fatty liver (hepatic steatosis). According to the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, hypercaloric diet with frequent meals increases intrahepatic triglyceride content (IHTG) and fat around the waist, but increasing meal size did not. Obesity is a global health concern with the World...

2014-05-06 16:31:52

CHICAGO, May 6, 2014 /PRNewswire/ -- Research presented this week at Digestive Disease Week® (DDW) provides insight into the development and new treatments of diseases, such as nonalcoholic fatty liver disease, colorectal cancer and ulcers. Key studies presented include: -- Weight-loss surgery can reduce liver damage. Bariatric surgery, which is best known for its ability to help patients lose weight, can also result in improvement in nonalcoholic fatty liver disease...

2014-04-14 12:30:21

A UK study investigating the link between low vitamin D status and non-alcoholic fatty liver disease (NAFLD) in British children has identified a genetic variant associated with the disease's severity. The research, conducted by the King's College Hospital Paediatric Liver Centre and the University of Surrey's School of Biosciences and Medicine, and funded by the Children's Liver Disease Foundation retrospectively analyzed the medical records of 120 pediatric patients with NAFLD. The...

2014-04-10 13:46:07

Two new studies presented today at the International Liver CongressTM 2014 have provided more evidence to clarify the role of non-alcoholic fatty liver disease (NAFLD) as an independent risk factor for the development of cardiovascular disease (CVD). In the first long-term study , in patients at high CVD risk, NAFLD was shown to contribute to the progression of early atherosclerosis independently of traditional CVD risk factors. In a second long-term study , NAFLD was confirmed as a...

2014-03-30 23:01:42

Frank R. Sinatra, MD, Professor of Pediatrics and Assistant Dean for Faculty Development, Keck School of Medicine, University of Southern California, Los Angeles, presented on Hepatitis C: Progress and Challenges, Nonalcoholic Fatty Liver Disease: Part of a Bigger Problem. Glendale, CA (PRWEB) March 30, 2014 Audio-Digest Foundation Announces the Release of Pediatrics Volume 60, Issue 02: Hepatitis C/Nonalcoholic Fatty Liver Disease. The goals of this program are to improve the management...

2014-03-22 23:03:03

ReportsnReports.com offers "OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update" 2014 market research report in its store. Dallas, TX (PRWEB) March 22, 2014 OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update report estimates the 2012 off-label sales for nonalcoholic steatohepatitis (NASH) to be approximately $233m across the US and five...

2014-03-11 08:29:53

Funding to support clinical development of treatments for rare cholestatic liver diseases and nonalcoholic steatohepatitis SAN DIEGO, March 11, 2014 /PRNewswire/ -- Lumena Pharmaceuticals (Lumena), a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, today announced that it has secured $45 million in Series B financing. New Enterprise Associates (NEA) led the financing,...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related